Gufic Biosciences share news, announcements and annual reports
NSE: GUFICBIOBSE: 509079Pharmaceuticals & BiotechnologySmall Cap
Gufic Biosciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1985 on BSE, Oct 2004 on NSE
Last close ₹413.55down ₹5.25 (1.25%)BSE ₹412.20
Share price at the NSE close on 30 Oct 2026. Previous close ₹418.80.
30 Oct: open ₹416.90, high ₹423.00, low ₹407.70
52-week range of traded prices to 30 Oct 2026
₹268.00Low, 9 Mar 2026₹467.80High, 7 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,147 Cr959th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 56.46
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.24
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 70,25448.5% delivered
Gufic Biosciences dividends
17 filed, newest first.
May 2026
May 2024
29 May · Dividend
May 2023
May 2022
Jun 2021
4 Jun · Dividend
Aug 2020
Aug 2019
May 2017
May 2016
May 2015
30 May · Dividend
Board of Directors of the Company at its meeting held on May 29, 2015 has recommended a final dividend of Re 0.05 per equity shares. This proposal is subject to approval of shareholders at the ensuing Annual General Meeting.
Aug 2014
28 Aug · Dividend
Board of Directors of the Company at its meeting held on August 27, 2014 has recommended a dividend of Re 0.05 per share on equity share of Rs.1/- each as a final dividend for the Financial Year 2013-14.
May 2013
31 May · Dividend
Board of Directors of the Company at their meeting held on May 30, 2013 has recommended dividend @5% per share (i.e.Rs.0.05 per share).
Jul 2012
10 Jul · Dividend
Board of Directors of the Company at its meeting held on July 10, 2012 has recommended dividend @ 5% per share (i.e. Re. 0.05 per share).
Sep 2011
2 Sep · Dividend
Board of Directors of the Company at its meeting held on August 30, 2011 has decided to declare dividend @ 5% per share (i.e. Re.0.05 per share) subject to shareholders approved at the Annual General Meeting.
Aug 2010
31 Aug · Dividend
Board of Directors of the Company at its meeting held on August 30, 2010 has decided to declare dividend @ 5% per share (i.e. Re.0.05 per share) subjected to shareholders approval at the Annual General Meeting.
Mar 2008
10 Mar · Dividend
Dividend on the Equity shares of the Company proposed to be declared at the Annual General Meeting of the Company to be held on March 31, 2008, if approved by the shareholders, will be paid on or before April 30, 2008.